Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Cytoprotective Effects of Nebivolol

This is a preview of subscription content, log in to check access.

References

  1. Borgers M, Thoné F, Verheyen A, ter Keurs HEDJ. Localization of calcium in skeletal and cardiac muscle. Histochemical Journal 16: 295–309, 1984

  2. Borgers M, Ver Donck L, Vandeplassche G. Pathophysiology of cardiomyocytes. Annals of the New York Academy of Sciences 522: 433–453, 1988

  3. Lu HR, Vandeplassche G, Wouters L, Borgers M. β-Blockade in the ischemic reperfused working rabbit heart: dissociation of β-adrenergic blocking and protective effects. Archives Internationales de Pharmacodynamie et de Thérapie 301: 165–181, 1989

  4. Lu HR, Vandeplassche G, Wouters L, Flameng W, Borgers M. Effects of β-adrenoeeptor antagonists on cardiac function in ischemic-reperfused myocardium of the isolated working rabbit heart. European Journal of Pharmacology 184: 65–74, 1990

  5. Van de Water A, Janssens W, Van Nueten J, Xhonneux R, De Cree J, et al. Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective β1-adrenergic antagonist. Journal of Cardiovascular Pharmacology 11: 552–563, 1988

Download references

Author information

Correspondence to Dr G. Vandeplassche.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Vandeplassche, G., Ver Donck, L., Lu, H.R. et al. Cytoprotective Effects of Nebivolol. Drug Invest 3, 134–136 (1991). https://doi.org/10.1007/BF03258282

Download citation

Keywords

  • Propranolol
  • Atenolol
  • Ouabain
  • Nebivolol
  • Cytoprotective Effect